THE placenta, one of the most important fetal tissues during gestation, ensures nutrition, development and protection of the fetus. Although placenta lacks expression of class II MHC antigens, they can be induced either by interferon-gamma (IFN-y) on the spongiotrophoblast zone, or by 5-azacytidine (5-azaC) on the labyrinthine trophoblast zone, two agents actively participating in a plethora of imInunological and inflammatory reactions. This induction is correlated with fetal abortion and fetal developmental abnormalities. In this work the in vitro and in vivo signal transduction pathways followed by IFN-y or 5- (10, 20, 30btM) tion with the demethylating agent 5-azaC in vitro showed that the best working conditions are as well as in vivo. 8'9 In both systems studied, obtained with 10 (Fig. I(B) ). Thus (Fig. 1(C) (Fig. I(D) (Fig. 3(A) ). Furthermore,
In order to test whether the in vitro results SPH and St inhibit the expression of these antidescribed above can also be applied in vivo, gens by 75% and 97% (p< 0.001) respectively pregnant mice were injected with IFN-, and inhi- (Fig. 3(B) ), whereas the application of MEV gives bitors (doses and timing given in Methods). On 100% inhibition of Ia antigen expression the I2th day of pregnancy, the mice were sacri-( Fig. 3(C) ). The TK pathway does not seem to be involved in this system, since genistein does not affect the 5-azaC-induced expression of these antigens on placental cells (Fig. 3(D) ). All these inhibitors were used at the same doses as those described for IFN-(. Application of these inhibitors in order to examine changes at the p21 ras expression levels, showed that only MEV could block the appearance of the p21 ra= proteins (Fig. 4) . Administra 
